J.P. Morgan Roundtable: Financing Challenges, And Opportunities, For Complex Therapies

Part 1: Scrip spoke with companies working on cell and gene therapies and novel neuroscience platforms – areas difficult to finance in the past, but seeing increasing investor interest – about funding challenges and opportunities in 2019.